Published on 10 May 2023 on Simply Wall St. via Yahoo Finance
Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of...
As an investor, mistakes are inevitable. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) investors who have held the stock for three years as it declined a whopping 82%. That would be a disturbing experience. The falls have accelerated recently, with the share price down 19% in the last three months. We note that the company has reported results fairly recently; and the market is hardly delighted. You can check out the latest numbers in our company report. We really hope anyone holding through that price crash has a diversified portfolio. Even when you lose money, you don't have to lose the lesson.
While the stock has risen 8.5% in the past week but long term shareholders are still in the red, let's see what the fundamentals can tell us.
View our latest analysis for Adaptive Biotechnologies